- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 950.3K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 916.97K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 172.26K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.98M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $12.84M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $17.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.25M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $10.34M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.29M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$2.02M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.38M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.49M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.64M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.52M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $16.75M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $21.98M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $157.16M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $162.4M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$21.28 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$70.16 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$21.28 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$70.16 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.22M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $951.65K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $5.11M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.22M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$17.79M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$12.09M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$17.76M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.17M |